J, K., U, M., & H, S. (2012). Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure. Dove Medical Press.
Cita Chicago Style (17a ed.)J, Kekow, Mueller-Ladner U, y Schulze-Koops H. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
Cita MLA (8a ed.)J, Kekow, et al. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
Precaución: Estas citas no son 100% exactas.